Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP in ADHF and AKI
NCT01625403Phase 2Unknown
- Sponsor
- Shanghai Chest Hospital
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nesiritide in Acute Heart Failure (AHF), acute kidney injury (AKI), sponsored by Shanghai Chest Hospital. Status: unknown.
02
Drugs
nesiritide
03
Conditions
Acute Heart Failure (AHF)acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01625403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625403.